HIV protease inhibitors.
Carr
A
A
HIV Medicine Unit, St Vincent's Hospital, Sydney, Australia.
Cooper
D A
DA
D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000737:chemistry; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy*; D016333:HIV Protease / Q000737:chemistry; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology*; D019438:Ritonavir / Q000494:pharmacology*; D019258:Saquinavir / Q000494:pharmacology*
D017320:HIV Protease Inhibitors; D019469:Indinavir; D016282:Aspartic Acid Endopeptidases; D016333:HIV Protease; C065184:p16 protease, Human immunodeficiency virus 2; D019258:Saquinavir; D019438:Ritonavir